FL - Bristol Myers' Breyanzi gains additional indication for follicular lymphoma
2024-05-15 17:36:48 ET
More on Bristol-Myers Squibb
- Bristol-Myers Squibb: A Lost Decade?
- Bristol Myers Squibb: Tough Times Continue
- Bristol Myers' Opdivo fails in Phase 3 lung cancer study
- FDA accepts Bristol Myers application for injected Opdivo
- Bristol-Myers Squibb Company (BMY) Presents at Guggenheim Securities Radiopharmaceuticals Day (Transcript)